Point Biopharma shares sink after pricing new stock offering at discount
Indianapolis-based biotech firm Point Biopharma Global Inc. hopes to raise about $125 million in the offering, before underwriting expenses and deductions.
Indianapolis-based biotech firm Point Biopharma Global Inc. hopes to raise about $125 million in the offering, before underwriting expenses and deductions.
The poll from The Associated Press-NORC Center for Public Affairs Research reveals public satisfaction with the U.S. health care system is remarkably low, with fewer than half of Americans saying it’s handled well in general.
The partners will utilize the Indiana Network for Patient Care, which was created by Regenstrief and is managed by the Indiana Health Information Exchange, to mine data from electronic health records.
The ruling Wednesday was a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year.
The federal government has purchased more than 170 million doses of the updated boosters, and doses began shipping last week, following authorization by the Food and Drug Administration.
The acquisition would continue CVS’ effort to grow from its pharmacy-chain roots to other sectors of the health industry.
Indiana and its investment managers can’t make government employee pension system investments based on environmental, social or governance criteria, Attorney General Todd Rokita wrote in an advisory opinion released Thursday.
CDC’s advisers deemed the updated injections the best option considering the U.S. still is experiencing tens of thousands of COVID-19 cases and about 500 deaths every day—even before an expected new winter wave.
Indiana University Health, the state’s largest hospital system, has set up the teams to help its doctors seeking guidance on whether they can legally perform an abortion to protect the health of the mother and other situations.
Public health experts said the decision will make it harder for people to access coronavirus tests, especially for those who are uninsured, live in remote areas far from distribution centers or face mobility issues.
In the first two years of the COVID-19 pandemic, the estimated American lifespan has shortened by nearly three years. The last comparable decrease happened in the early 1940s, during the height of World War II.
The Franklin-based health system said it will become part of the Mayo Clinic Care Network, an operation that allows independent hospitals to tap into the giant health organization’s vast system of specialists and researchers to help solve medical problems.
A review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency’s commissioner said Tuesday.
Indiana still has 43% of its $1 billion-plus in federal COVID-19 grants left to spend, according to Indiana State Department of Health data.
The company, which has developed a workflow and collaboration software platform designed to improve post-acute care outcomes for patients, said it plans to use the funding to further product development and make key hires in several departments.
COVID-19 vaccine maker Moderna accuses competitors Pfizer and BioNTech of copying Moderna’s technology in order to make their own vaccine.
In January, the cost of insulin for patients on Medicare will be capped at $35 a month. But that cap doesn’t apply to those with private insurance, which is used by the majority of those in need of insulin.
The researchers found that Paxlovid reduced hospitalizations among people 65 and older by roughly 75% when given shortly after infection. But people between the ages of 40 and 65 saw no measurable benefit, according to the analysis of medical records.
Amazon is closing the hybrid virtual, in-home care service it’s spent years developing, a surprising move that underscores the challenges it faces as it moves into health care.
U.S. legislation requiring price negotiation for top-selling medicines will delay the launch of new drugs, AstraZeneca CEO Pascal Soriot warned.